Clinical Trials

1 2 3 210
Number of results: 4198

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2018-03-03 DX-2930 - lanadelumab type 1 and type 2 hereditary angioedema (HAE) 3 Dyax (USA - MA), now Shire (UK - USA) Rare diseases - Genetic diseases - Hematological diseases
2018-02-15 Otezla® (apremilast) ulcerative colitis 2 Celgene (USA - NJ) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2018-02-15 OPRX-106 ulcerative colitis 2 Protalix BioTherapeutics (Israel) Autoimmune diseases - Inflammatory diseases - Digestive diseases
2018-02-12 Chronocort® (hydrocortisone modified release capsules) congenital adrenal hyperplasia (CAH) 3 Diurnal Limited (UK) Rare diseases - Endocrine diseases - Hormonal diseases
2018-02-08 ABO-102 (SC AAV-SGSH) mucopolysaccharidosis type IIIA (Sanfilippo B syndrome) 1-2 Abeona Therapeutics (USA - NY) Rare diseases - Genetic diseases
2018-02-07 ABO-101 (AAV NAGLU) mucopolysaccharidosis type IIIB (MPS IIIB or Sanfilippo syndrome Type B) 1-2 Abeona Therapeutics (USA - NY) Rare diseases
2018-02-05 Rolontis™ (eflapegrastim) chemotherapy-induced neutropenia in patients with breast cancer. 3 Spectrum Pharmaceuticals (USA - NV) Cancer - Oncology - Hematological diseases
2018-01-24 Traumakine® - FP-1201 (human recombinant interferon-beta 1a) acute respiratory distress syndrome (ARDS) 1 Faron Pharmaceuticals (Finland) Lung diseases - Respiratory diseases - Rare diseases
2018-01-18 BM32 grass pollen allergy 2 Biomay (Austria) Allergic diseases
2018-01-10 GS030 retinitis pigmentosa 1-2 Gensight Biologics (France) Rare diseases - Genetic diseases - Ophtalmological diseases
2018-01-08 AR101 peanut allergy 3 Aimmune Therapeutics (USA - CA) previously Allergen Research Corporation (ARC) Allergic diseases
2018-01-08 Tesomet® (tesofensine) Prader-Willi syndrome 2a Saniona (Denmark) Rare diseases - Genetic diseases - Metabolic diseases
2018-01-08 MIV-818 preclinical Medivir (Sweden)
2018-01-08 MAGE A10c796T - autologous genetically modified T-cells expressing enhanced T cell receptors (TCRs) specific for MAGE A10 locally advanced or metastatic (Stage IIIb or IV) non-small cell lung cancer (NSCLC) 1-2 Adaptimmune (UK) Cancer - Oncology
2018-01-08 ACE 083 facioscapulohumeral muscular dystrophy (FSHD) 2 Acceleron Pharma (USA - CA) Rare diseases - Genetic diseases - Neuromuscular diseases
2018-01-05 ISIS 678354 (AKCEA-APOCIII-LRx) patients with hypertriglyceridemia and established cardiovascular disease 2b Akcea Therapeutics (USA - CA), a subsidiary of Ionis Pharmaceuticals (USA - CA) Cardiovascular diseases
2018-01-05 M281 autoimmune diseases 1 Momenta Pharmaceuticals (USA - MA) Autoimmune diseases
2018-01-04 BioChaperone® glucagon exenatide obesity Adocia (France) Metabolic diseases
2018-01-04 BioChaperone® teduglutide short bowel syndrome Adocia (France) Rare diseases - Gastrointestinal diseases
2018-01-04 ABX464 ulcerative colitis 2a Abivax (France) Autoimmune diseases - Inflammatory diseases - Digestive diseases